Mutational analysis of parkin and PINK1 in multiple system atrophy

Neurobiology of Aging

Volumn 32, Issue 3, 2011, Pages 548.e5-548.e7

  Brooks, Janet A ^a   Houlden, Henry ^b   Melchers, Anna ^b   Islam, Ansha J ^a   Ding, Jinhui ^a   Li, Abi ^b   Paudel, Reema ^b   Revesz, Tamas ^b   Holton, Janice L ^b   Wood, Nick ^b   Lees, Andrew ^b   Singleton, Andrew B ^a   Scholz, Sonja W ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Multiple system atrophy; Parkin; Parkinson's disease; PINK1

Indexed keywords

ARGININE; GLYCINE; PARKIN; PHOSPHOTRANSFERASE; PINK1 PROTEIN; PTEN INDUCED PUTATIVE KINASE 1; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE DELETION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN VARIANT; SHY DRAGER SYNDROME;

EID: 79952900675     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.11.020     Document Type: Article

References (7)

1. Brooks J., Ding J., Simon-Sanchez J., Paisan-Ruiz C., Singleton A.B., Scholz S.W. Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control. J. Med. Genet. 2009, 46(6):375-381.
2. Klein C., Lohmann-Hedrich K., Rogaeva E., Schlossmacher M.G., Lang A.E. Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol. 2007, 6(7):652-662.
3. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25(4):402-408.
4. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81(3):559-575.
5. Scholz S., Schulte C., PD Genetics Consortium Genome-Wide Association Study in Parkinson's Disease: Identification of Strong Associations with SNCA and MAPT. [Abstract program number 90] Presented at the annual meeting of The American Society of Human Genetics 2008.
6. Scholz S.W., Houlden H., Schulte C., Sharma M., Li A., Berg D., Melchers A., Paudel R., Gibbs J.R., Simon-Sanchez J., Paisan-Ruiz C., Bras J., Ding J., Chen H., Traynor B.J., Arepalli S., Zonozi R.R., Revesz T., Holton J., Wood N., Lees A., Oertel W., Wullner U., Goldwurm S., Pellecchia M.T., Illig T., Riess O., Fernandez H.H., Rodriguez R.L., Okun M.S., Poewe W., Wenning G.K., Hardy J.A., Singleton A.B., Gasser T. SNCA variants are associated with increased risk for multiple system atrophy. Ann. Neurol. 2009, 65(5):610-614.
7. Spillantini M.G., Crowther R.A., Jakes R., Cairns N.J., Lantos P.L., Goedert M. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett. 1998, 251(3):205-208.